Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia

Jonathan A Rose, MS, Tamara J. Dunn, MD, Michaela Liedtke, MD, Paul Elson, ScD, Matt Kalaycio, MD, Ed Copelan, MD, Ronald Sobecks, MD, Mikkael A. Sekeres, MD, MS, Sean Hobson, Laura Johnston, MD, Shawnda Tench, Sharisa Cross, Anjali Advani, MD

Blood (2012) 120 (21): 1472.

https://doi.org/10.1182/blood.V120.21.1472.1472

Published: 2012

Journal Articles

Obese Patients Have Improved Survival Following Autologous Hematopoietic Stem Cell Transplantation

Hien K. Duong, MD, Anna Koo, MD, Lisa Rybicki, MS, Ed Copelan, Matt Kalaycio, MD, Ronald Sobecks, MD, Robert M Dean, MD, Brian T. Hill, MD, PhD, Sarah L. Ondrejka, DO, Donna M Abounader, Brad Pohlman, MD, Brian J. Bolwell, MD

Blood (2012) 120 (21): 1989.

https://doi.org/10.1182/blood.V120.21.1989.1989

Published: 2012

Journal Articles

Low Vitamin D Levels After Allogeneic Hematopoietic Stem Cell Transplant.

Lisa Sproat, MD, MSW, Brian J. Bolwell, Lisa Rybicki, Robert Dean, Ronald Sobecks, Brad Pohlman, Steven Andresen, John Sweetenham, Ed Copelan, Matt Kalaycio

Blood (2009) 114 (22): 3322.

https://doi.org/10.1182/blood.V114.22.3322.3322

Published: 2009

Journal Articles

No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics.

Lisa O. Sproat, MD, MSW, Brian Bolwell, Lisa Rybicki, Matt Kalaycio, Robert Dean, Ronald Sobecks, Brad Pohlman, Steve Andresen, Shawnda Sungren, Josephine Chan, John Sweetenham, Ed Copelan

Blood (2008) 112 (11): 2164.

https://doi.org/10.1182/blood.V112.11.2164.2164

Published: 2008

Journal Articles

Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Sanjay R. Mohan, MD, Paul Elson, ScD, Cristina Rodriguez, MD, Rachid Baz, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Anjali Advani, MD, Ed Copelan, MD, Lukasz P. Gondek, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS

Blood (2008) 112 (11): 921.

https://doi.org/10.1182/blood.V112.11.921.921

Published: 2008

Journal Articles

Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics.

Anjali S. Advani, MD, Sarah Gibson, MD, Tao Jin, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Mikkael A. Sekeres, MD, Ed Copelan, MD, Shawnda Sungren, BBA, Eric D. Hsi, MD

Blood (2007) 110 (11): 2798.

https://doi.org/10.1182/blood.V110.11.2798.2798

Published: 2007

Journal Articles

A Phase 1 Trial of Imatinib Mesylate in Combination with Daunorubicin and Cytarabine for Patients for C-kit Positive Relapsed Acute Myeloid Leukemia (AML).

Anjali S. Advani, MD, Ronald Sobecks, MD, Mikkael A. Sekeres, MD, Ed Copelan, MD, Jennifer Bates, Barbara Tripp, RN, August Salvado, MD, Matt Kalaycio, MD

Blood (2007) 110 (11): 906.

https://doi.org/10.1182/blood.V110.11.906.906

Published: 2007

NARROW

Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia

Obese Patients Have Improved Survival Following Autologous Hematopoietic Stem Cell Transplantation

Low Vitamin D Levels After Allogeneic Hematopoietic Stem Cell Transplant.

No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics.

Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics.

A Phase 1 Trial of Imatinib Mesylate in Combination with Daunorubicin and Cytarabine for Patients for C-kit Positive Relapsed Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia

Obese Patients Have Improved Survival Following Autologous Hematopoietic Stem Cell Transplantation

Low Vitamin D Levels After Allogeneic Hematopoietic Stem Cell Transplant.

No Impact of Postremission Consolidation Chemotherapy Before Allogeneic Transplant in Patients with First Remission Acute Myeloid Leukemia with Intermediate or High Risk Cytogenetics.

Development of a Prognostic Scoring System for Secondary Acute Myeloid Leukemia (sAML) Arising from Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).

Histone H4 Acetylation Is Associated with Improved Relapse-Free Survival in Newly Diagnosed Patients with Acute Lymphoblastic Leukemia (ALL) Less Than 60 Years of Age without Poor Risk Cytogenetics.

A Phase 1 Trial of Imatinib Mesylate in Combination with Daunorubicin and Cytarabine for Patients for C-kit Positive Relapsed Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only